Biomarin Pharmaceutical (BMRN) Tax Rate (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Tax Rate of 25.27% for Q1 2026, up 135.33% on a QoQ basis from 71.52% in Q4 2025, and up 326.0% year-over-year from 5.93% in Q1 2025.
Biomarin Pharmaceutical (BMRN) Tax Rate (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical's Tax Rate history runs 18 years deep, the most recent figure standing at 25.27% for Q1 2026.
- Quarterly Tax Rate rose 326.0% year-over-year to 25.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 30.3% (up 800.0% YoY) and the FY2025 annual result came in at 27.69%, up 648.0% from the prior year.
- Tax Rate was 25.27% for Q1 2026 at Biomarin Pharmaceutical, up from 71.52% in the prior quarter.
- Across five years, Tax Rate topped out at 98.58% in Q4 2022 and bottomed at 249.37% in Q3 2022.
- A 5-year average of 1.81% and a median of 18.89% in 2024 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2022 — Tax Rate slumped 27031 bps — and 2023, when it surged 25247 bps.
- Biomarin Pharmaceutical's Tax Rate stood at 98.58% in 2022, then slumped by 106 bps to 5.42% in 2023, then jumped by 586 bps to 26.35% in 2024, then plunged by 371 bps to 71.52% in 2025, then surged by 135 bps to 25.27% in 2026.
- Business Quant data shows BMRN's Tax Rate at 25.27% in Q1 2026, 71.52% in Q4 2025, and 16.79% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | 25.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.27% |
| Mar 31, 2026 | 25.27% |
| Mar 31, 2026 | 25.27% |
| Dec 31, 2025 | -71.52% |
| Dec 31, 2025 | -71.52% |
| Dec 31, 2025 | -71.52% |
| Sep 30, 2025 | -16.79% |
| Sep 30, 2025 | -16.79% |
| Sep 30, 2025 | -16.79% |
| Jun 30, 2025 | 19.25% |
| Jun 30, 2025 | 19.25% |
| Jun 30, 2025 | 19.25% |
| Mar 31, 2025 | 22.01% |
| Mar 31, 2025 | 22.01% |
| Mar 31, 2025 | 22.01% |
| Dec 31, 2024 | 26.35% |
| Dec 31, 2024 | 26.35% |
| Dec 31, 2024 | 26.35% |
| Sep 30, 2024 | 21.10% |
| Sep 30, 2024 | 21.10% |